Orion Pharma Limited (DSE:ORIONPHARM)

Bangladesh · Delayed Price · Currency is BDT

28.80

-0.70 (-2.37%)

At close: Jul 23, 2026

Orion Pharma Financials Overview

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	3,011	4,082	10,621	13,927	9,662	10,833
Revenue Growth	-51.37%	-61.57%	-23.74%	44.14%	-10.81%	41.64%
Gross Profit	1,091	1,376	2,273	2,275	1,969	2,635
Operating Income	-134.87	55.9	929.02	992.96	675.12	1,538
Net Income	-595.3	-415.28	318.12	640.94	846.08	939.06
Earnings Per Share	-2.54	-1.77	1.36	2.74	3.62	4.01
EPS Growth	-	-	-50.37%	-24.25%	-9.90%	41.07%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Jun '25 Jun 30, 2025
Power	817.57
Pharmaceuticals	3,264
Total	4,082

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	161.28	138.07	209.87	196.37	172.92	467.86
Total Debt	27,039	25,677	23,762	21,897	18,619	16,844
Net Cash (Debt)	-26,878	-25,539	-23,552	-21,700	-18,446	-16,377
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-114.86	-109.14	-100.65	-92.74	-78.83	-69.99

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	821.8	1,104	1,587	2,493	1,162	2,592
Capital Expenditures	-421	-767.16	-1,948	-3,859	-2,667	-4,277
Free Cash Flow	400.8	336.97	-361.87	-1,366	-1,505	-1,685
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	36.23%	33.71%	21.40%	16.33%	20.38%	24.32%
Operating Margin	-4.48%	1.37%	8.75%	7.13%	6.99%	14.20%
Pretax Margin	-18.62%	-9.28%	5.02%	6.04%	11.01%	11.02%
Profit Margin	-19.77%	-10.17%	3.00%	4.60%	8.76%	8.67%
FCF Margin	13.31%	8.25%	-3.41%	-9.81%	-15.58%	-15.56%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Dividend Per Share	1.000	1.000	1.000	1.200
Dividend Per Share Growth	0%	0%	-16.67%	20.00%
Dividend Yield	1.48%	1.31%	1.19%	2.37%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	-	-	50.83	29.06	24.34	13.43
P/FCF Ratio	16.81	21.04	-	-	-	-
PS Ratio	2.24	1.74	1.52	1.34	2.13	1.16